Ascentage Pharma Group International (ASPHF)
USD 2.69
(0.0%)
USD 2.69
(0.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 1.17 Billion CNY | -7.47% |
| 2022 | 1.27 Billion CNY | 23.14% |
| 2021 | 1.03 Billion CNY | 115.98% |
| 2020 | 479.13 Million CNY | 5101.76% |
| 2019 | 9.21 Million CNY | 106.66% |
| 2018 | 4.45 Million CNY | 54.81% |
| 2017 | 2.87 Million CNY | 509.96% |
| 2016 | 472 Thousand CNY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 Q2 | 1.27 Billion CNY | 0.0% |
| 2023 Q4 | 1.17 Billion CNY | 0.0% |
| 2023 FY | 1.17 Billion CNY | -7.47% |
| 2023 Q3 | 1.17 Billion CNY | -7.21% |
| 2023 Q1 | 1.27 Billion CNY | -0.28% |
| 2022 Q4 | 1.27 Billion CNY | 0.0% |
| 2022 Q2 | 1.24 Billion CNY | 0.0% |
| 2022 Q1 | 1.24 Billion CNY | 20.72% |
| 2022 FY | 1.27 Billion CNY | 23.14% |
| 2022 Q3 | 1.27 Billion CNY | 2.01% |
| 2021 Q4 | 1.03 Billion CNY | 0.0% |
| 2021 FY | 1.03 Billion CNY | 115.98% |
| 2021 Q3 | 1.03 Billion CNY | 63.28% |
| 2021 Q2 | 633.79 Million CNY | 0.0% |
| 2021 Q1 | 633.79 Million CNY | 32.28% |
| 2020 Q2 | 219.61 Million CNY | 0.0% |
| 2020 FY | 479.13 Million CNY | 5101.76% |
| 2020 Q4 | 479.13 Million CNY | 0.0% |
| 2020 Q3 | 479.13 Million CNY | 118.17% |
| 2020 Q1 | 219.61 Million CNY | 2284.27% |
| 2019 Q3 | 9.21 Million CNY | -28.89% |
| 2019 Q2 | 12.95 Million CNY | -99.47% |
| 2019 Q1 | 2.43 Billion CNY | 54624.79% |
| 2019 FY | 9.21 Million CNY | 106.66% |
| 2019 Q4 | 9.21 Million CNY | 0.0% |
| 2018 Q3 | 2.08 Billion CNY | 0.0% |
| 2018 FY | 4.45 Million CNY | 54.81% |
| 2018 Q4 | 4.45 Million CNY | -99.79% |
| 2018 Q1 | - CNY | 0.0% |
| 2017 FY | 2.87 Million CNY | 509.96% |
| 2016 FY | 472 Thousand CNY | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | - USD | -Infinity% |
| Nanobac Pharmaceuticals, Incorporated | - USD | -Infinity% |
| SQZ Biotechnologies Company | 20.9 Million USD | -5539.634% |
| Evofem Biosciences, Inc. | 8000.00 USD | -14739787.5% |
| Santhera Pharmaceuticals Holding AG | 1.75 Million USD | -67072.037% |
| Mesoblast Limited | 100.29 Million USD | -1075.723% |
| Propanc Biopharma, Inc. | 58.64 Thousand USD | -2010730.122% |
| Genus plc | 228.2 Million USD | -416.736% |
| VioQuest Pharmaceuticals, Inc. | - USD | -Infinity% |
| CNBX Pharmaceuticals Inc. | - USD | -Infinity% |
| Marizyme, Inc. | 667.12 Thousand USD | -176656.07% |
| ContraFect Corporation | 2.21 Million USD | -53257.059% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| PsyBio Therapeutics Corp. | - USD | -Infinity% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 1.4 Million USD | -83951.78% |
| Intellipharmaceutics International Inc. | - USD | -Infinity% |
| AXIM Biotechnologies, Inc. | 5.42 Million USD | -21630.311% |
| MultiCell Technologies, Inc. | 36.43 USD | -3236867865.962% |
| Accustem Sciences Inc. | - USD | -Infinity% |
| RVL Pharmaceuticals plc | 55.61 Million USD | -2020.389% |
| EV Biologics, Inc. | - USD | -Infinity% |
| Q BioMed Inc. | - USD | -Infinity% |
| Emmaus Life Sciences, Inc. | 2.22 Million USD | -52873.54% |
| Neon Bloom, Inc. | - USD | -Infinity% |
| Mosaic ImmunoEngineering Inc. | 1.22 Million USD | -95897.105% |
| Biomind Labs Inc. | - USD | -Infinity% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Pharming Group N.V. | 166.1 Million USD | -609.907% |
| Oncotelic Therapeutics, Inc. | 1.89 Million USD | -62012.767% |
| Skye Bioscience, Inc. | 171.23 Thousand USD | -688559.113% |
| Therapeutic Solutions International, Inc. | 5512.00 USD | -21393060.377% |
| THC Farmaceuticals, Inc. | - USD | -Infinity% |
| Arch Therapeutics, Inc. | - USD | -Infinity% |
| IMV Inc. | 27.39 Million USD | -4203.841% |
| Acro Biomedical Co., Ltd. | - USD | -Infinity% |
| Curative Biotechnology, Inc. | - USD | -Infinity% |
| GB Sciences, Inc. | 322 Thousand USD | -366108.385% |
| Alpha Cognition Inc. | - USD | -Infinity% |
| HST Global, Inc. | - USD | -Infinity% |
| CSL Limited | 11.23 Billion USD | 89.508% |
| Halberd Corporation | 150 Thousand USD | -786027.333% |
| Enzolytics Inc. | - USD | -Infinity% |
| Resverlogix Corp. | - USD | -Infinity% |
| Affymax, Inc. | - USD | -Infinity% |
| SYBLEU INC | 300 Thousand USD | -392963.667% |
| Nuo Therapeutics, Inc. | 164.2 Thousand USD | -718021.251% |
| argenx SE | 15.35 Million USD | -7580.025% |
| MetaStat, Inc. | - USD | -Infinity% |
| Northwest Biotherapeutics, Inc. | 20.31 Million USD | -5705.391% |
| Enzon Pharmaceuticals, Inc. | - USD | -Infinity% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| RespireRx Pharmaceuticals Inc. | - USD | -Infinity% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | - USD | -Infinity% |
| AVAX Technologies, Inc. | - USD | -Infinity% |
| Zenith Capital Corp. | 4456.00 USD | -26462893.716% |
| Genscript Biotech Corporation | 287.12 Million USD | -310.683% |
| Ember Therapeutics, Inc. | - USD | -Infinity% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 126.3 Thousand USD | -933528.129% |
| WPD Pharmaceuticals Inc. | 229.29 Thousand USD | -514177.054% |
| American Oriental Bioengineering, Inc. | 554.59 Thousand USD | -212523.92% |
| Provectus Biopharmaceuticals, Inc. | 25.29 Thousand USD | -4660918.222% |
| Adynxx, Inc. | - USD | -Infinity% |
| Helix BioMedix, Inc. | - USD | -Infinity% |
| GlobeStar Therapeutics Corporation | - USD | -Infinity% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 8.26 Million USD | -14169.01% |
| Cotinga Pharmaceuticals Inc. | - USD | -Infinity% |
| BioStem Technologies, Inc. | 265.63 Thousand USD | -443814.017% |
| ONE Bio Corp. | 592.19 Thousand USD | -199021.071% |
| Reve Technologies, Inc. | 1064.00 USD | -110826121.805% |
| Burzynski Research Institute, Inc. | - USD | -Infinity% |
| Wesana Health Holdings Inc. | - USD | -Infinity% |
| Agentix Corp. | - USD | -Infinity% |
| LadRx Corporation | - USD | -Infinity% |
| Cell Source, Inc. | - USD | -Infinity% |
| ProtoKinetix, Incorporated | - USD | -Infinity% |
| Regen BioPharma, Inc. | 149.61 Thousand USD | -788055.52% |
| Regen BioPharma, Inc. | 149.61 Thousand USD | -788055.52% |
| NovAccess Global Inc. | - USD | -Infinity% |
| Endonovo Therapeutics, Inc. | - USD | -Infinity% |
| Itoco Inc. | - USD | -Infinity% |
| Rasna Therapeutics, Inc. | - USD | -Infinity% |
| Pathfinder Cell Therapy, Inc. | - USD | -Infinity% |
| Kadimastem Ltd | 229.69 Thousand USD | -513281.456% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Institute of Biomedical Research Corp. | - USD | -Infinity% |
| CytoDyn Inc. | 141 Thousand USD | -836205.674% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | - USD | -Infinity% |
| Mobile Lads Corp. | - USD | -Infinity% |
| NanoSphere Health Sciences Inc. | - USD | -Infinity% |
| Qrons Inc. | 80 Thousand USD | -1473888.75% |
| Alseres Pharmaceuticals, Inc. | 7.81 Million USD | -14979.246% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | - USD | -Infinity% |
| Rebus Holdings, Inc. | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | 369.04 Thousand USD | -319421.527% |
| International Stem Cell Corporation | 445 Thousand USD | -264886.742% |
| Bioxytran, Inc. | - USD | -Infinity% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | - USD | -Infinity% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | - USD | -Infinity% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 8.15 Million USD | -14368.601% |
| Adhera Therapeutics, Inc. | - USD | -Infinity% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | - USD | -Infinity% |
| Innovation Pharmaceuticals Inc. | 457 Thousand USD | -257928.665% |
| Neutra Corp. | - USD | -Infinity% |
| Windtree Therapeutics, Inc. | 1.16 Million USD | -101466.839% |
| PureTech Health plc | 18.25 Million USD | -6361.321% |
| Coeptis Therapeutics, Inc. | 150 Thousand USD | -786027.333% |
| IXICO plc | 275 Thousand USD | -428696.727% |
| IntelGenx Technologies Corp. | 11.83 Million USD | -9860.225% |
| Gelesis Holdings, Inc. | 26.3 Million USD | -4382.082% |
| CSL Limited | 11.23 Billion USD | 89.508% |
| Cellectis S.A. | 36.21 Million USD | -3156.431% |